Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05163119 · ClinicalTrials.gov registry record · NA

Randomized Trial on Mobile Technology and Young Drivers' Cellphone Use

A NA study of Cell Phone Use and Automobile Driving, sponsored by Motao Zhu.

Recruiting
Registry status
NA
Development phase
1,200
Enrollment target
1
Study location

NCT05163119: Recruiting NA study of Cell Phone Use and Automobile Driving, sponsored by Motao Zhu.

NCT05163119 is a NA study of Cell Phone Use and Automobile Driving that is actively recruiting participants, run by Motao Zhu. The registered enrollment target is 1,200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05163119, a NA study of Cell Phone Use and Automobile Driving, is actively recruiting participants, sponsored by Motao Zhu.

RECRUITING
Registry status
NA
Development phase
1,200 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to conduct a randomized controlled trial to determine the effects of a cellphone app and a driving mode intervention on driving behavior in drivers aged 18-24 years.

Primary Outcome

Number of calling occurrences, texting occurrences, and handheld phone use occurrences, per 1,000 miles driven. Higher numbers signify more calling, texting, and handheld cell phone use.

Interventions

  • BEHAVIORAL Commercial Cellphone-Blocking App (Active)
  • BEHAVIORAL Driving Mode

Study Locations (1)

Ohio

  • Nationwide Children's Hospital - Columbus

Trial Details

FieldValue
Enrollment Target 1,200 participants
Start Date 2022-11-09
Est. Completion 2026-06-30
Phase NA
Motao Zhu

2 total trials

What NCT05163119 shows while recruiting

NCT05163119 is an interventional study that assigns participants to a tested intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% lower).

The record links to 2 conditions, with Cell Phone Use appearing as the primary indexed condition, and to 2 interventions - of which Commercial Cellphone-Blocking App (Active) is the first listed.

NCT05163119 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT05163119 about?

NCT05163119 is a clinical study titled "Randomized Trial on Mobile Technology and Young Drivers' Cellphone Use". The purpose of this study is to conduct a randomized controlled trial to determine the effects of a cellphone app and a driving mode intervention on driving behavior in drivers aged 18-24 years.

What is the current status of trial NCT05163119?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,200 participants. The study started on 2022-11-09. Estimated completion is 2026-06-30.

What conditions does trial NCT05163119 study?

This clinical trial studies the following conditions: Cell Phone Use, Automobile Driving.

What interventions are being tested in trial NCT05163119?

The interventions under investigation include: Commercial Cellphone-Blocking App (Active) (BEHAVIORAL), Driving Mode (BEHAVIORAL).

Who is sponsoring clinical trial NCT05163119?

This trial is sponsored by Motao Zhu, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05163119 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT05163119's enrollment target sits among peer trials

1,200 83rd of 2000 higher than 1,912 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001987 · 1,200 participants

    Genetic Studies of Insulin and Diabetes

  • NCT00477100 · 1,200 participants

    Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer

  • NCT01209000 · 1,200 participants

    Nephrotic Syndrome Study Network

  • NCT01944332 · 1,200 participants · NA

    Gamete Treatment to Correct Fertilization Failure

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05163119, the US trial registry maintained by the National Library of Medicine. NCT05163119 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.